427 related articles for article (PubMed ID: 29770869)
1. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
[TBL] [Abstract][Full Text] [Related]
2. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.
Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N
Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine profile is critical in autocrine GH-triggered curcumin resistance engulf by atiprimod cotreatment in MCF-7 and MDA-MB-231 breast cancer cells.
Coker-Gurkan A; Ozakaltun B; Akdeniz BS; Ergen B; Obakan-Yerlikaya P; Akkoc T; Arisan ED
Mol Biol Rep; 2020 Nov; 47(11):8797-8808. PubMed ID: 33130987
[TBL] [Abstract][Full Text] [Related]
4. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
[TBL] [Abstract][Full Text] [Related]
5. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
Rabi T; Huwiler A; Zangemeister-Wittke U
Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of PI3K and NFκB promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells.
Berrak Ö; Akkoç Y; Arısan ED; Çoker-Gürkan A; Obakan-Yerlikaya P; Palavan-Ünsal N
Biomed Pharmacother; 2016 Feb; 77():150-60. PubMed ID: 26796279
[TBL] [Abstract][Full Text] [Related]
7. DENSpm overcame Bcl-2 mediated resistance against Paclitaxel treatment in MCF-7 breast cancer cells via activating polyamine catabolic machinery.
Akyol Z; Çoker-Gürkan A; Arisan ED; Obakan-Yerlikaya P; Palavan-Ünsal N
Biomed Pharmacother; 2016 Dec; 84():2029-2041. PubMed ID: 27881234
[TBL] [Abstract][Full Text] [Related]
8. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells.
Huang T; Chen Z; Fang L
Oncol Rep; 2013 Jan; 29(1):117-24. PubMed ID: 23076367
[TBL] [Abstract][Full Text] [Related]
10. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
11. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
12. Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9.
Jiang M; Huang O; Zhang X; Xie Z; Shen A; Liu H; Geng M; Shen K
Molecules; 2013 Jan; 18(1):701-20. PubMed ID: 23299550
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells.
Chiu TL; Su CC
Int J Mol Med; 2009 Apr; 23(4):469-75. PubMed ID: 19288022
[TBL] [Abstract][Full Text] [Related]
14. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma.
Qiao Q; Jiang Y; Li G
Anticancer Drugs; 2012 Jul; 23(6):597-605. PubMed ID: 22273827
[TBL] [Abstract][Full Text] [Related]
15. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion.
Kim SR; Park HJ; Bae YH; Ahn SC; Wee HJ; Yun I; Jang HO; Bae MK; Bae SK
Endocrinology; 2012 Feb; 153(2):554-63. PubMed ID: 22186408
[TBL] [Abstract][Full Text] [Related]
16. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
Xu J; Zuo D; Qi H; Shen Q; Bai Z; Han M; Li Z; Zhang W; Wu Y
Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
[TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
Liu Q; Loo WT; Sze SC; Tong Y
Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
[TBL] [Abstract][Full Text] [Related]
19. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
20. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
Int J Oncol; 2017 Mar; 50(3):893-902. PubMed ID: 28197640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]